Arkema Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Arkema ha un patrimonio netto totale di €7.5B e un debito totale di €4.4B, che porta il suo rapporto debito/patrimonio netto a 59.1%. Le sue attività totali e le sue passività totali sono rispettivamente €14.7B e €7.2B. L'EBIT di Arkema è €686.0M rendendo il suo rapporto di copertura degli interessi 20.2. Ha liquidità e investimenti a breve termine pari a €2.0B.

Informazioni chiave

59.1%

Rapporto debito/patrimonio netto

€4.41b

Debito

Indice di copertura degli interessi	20.2x
Contanti	€2.00b
Patrimonio netto	€7.45b
Totale passività	€7.20b
Totale attività	€14.66b

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Arkema S.A. (EPA:AKE) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Nov 09

Investors Can Find Comfort In Arkema's (EPA:AKE) Earnings Quality

Aug 08

Results: Arkema S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 05

We Think Arkema (EPA:AKE) Is Taking Some Risk With Its Debt

Jul 16

Arkema's (EPA:AKE) Shareholders Will Receive A Bigger Dividend Than Last Year

May 13

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.50

Apr 25

Is Arkema (EPA:AKE) A Risky Investment?

Mar 29

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.50

Mar 08

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 02

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Dec 30

An Intrinsic Calculation For Arkema S.A. (EPA:AKE) Suggests It's 37% Undervalued

Dec 15

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Nov 29

Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Sep 07

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 44%?

Aug 20

Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?

Aug 02

Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

May 28

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.40

May 13

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 25%?

May 09

Why Arkema S.A. (EPA:AKE) Could Be Worth Watching

Apr 24

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.40

Apr 05

Arkema's (EPA:AKE) Dividend Will Be Increased To €3.40

Feb 26

Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Feb 14

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 31%?

Jan 30

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Jan 14

Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

Nov 02

At €76.10, Is Arkema S.A. (EPA:AKE) Worth Looking At Closely?

Oct 11

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Jul 19

What Is Arkema S.A.'s (EPA:AKE) Share Price Doing?

Jul 04

If You Like EPS Growth Then Check Out Arkema (EPA:AKE) Before It's Too Late

Jun 03

Arkema's (EPA:AKE) Upcoming Dividend Will Be Larger Than Last Year's

May 10

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Apr 25

Is There An Opportunity With Arkema S.A.'s (EPA:AKE) 47% Undervaluation?

Apr 24

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.00

Apr 10

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Mar 27

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( €5.1B ) di AKE superano le sue passività a breve termine ( €2.4B ).

Passività a lungo termine: Le attività a breve termine di AKE ( €5.1B ) superano le sue passività a lungo termine ( €4.8B ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 32.4% ) di AKE è considerato soddisfacente.

Riduzione del debito: Il rapporto debito/patrimonio netto di AKE è aumentato da 46.6% a 59.1% negli ultimi 5 anni.

Copertura del debito: Il debito di AKE è ben coperto dal flusso di cassa operativo ( 26.7% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di AKE sono ben coperti dall'EBIT ( 20.2 x copertura).

Arkema Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

We Think Arkema (EPA:AKE) Is Taking Some Risk With Its Debt

Is Arkema (EPA:AKE) A Risky Investment?

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Recent updates

Arkema S.A. to Report First Half, 2025 Results on Jul 31, 2025

Arkema S.A. (EPA:AKE) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Third quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Arkema S.A. to Report Q1, 2025 Results on May 07, 2025

Arkema Launches Ethyl Acrylate Based Entirely on Bioethanol

Arkema S.A. Announces Management Changes

Investors Can Find Comfort In Arkema's (EPA:AKE) Earnings Quality

Results: Arkema S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Arkema S.A. to Report Fiscal Year 2024 Results on Feb 27, 2025

We Think Arkema (EPA:AKE) Is Taking Some Risk With Its Debt

Consensus EPS estimates fall by 11%

Arkema's (EPA:AKE) Shareholders Will Receive A Bigger Dividend Than Last Year

Upcoming dividend of €3.50 per share

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Arkema S.A. (ENXTPA:AKE) agreed to acquire The Dow Chemical Company from Dow Inc. (NYSE:DOW) for an enterprise value of $150 million.

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.50

Is Arkema (EPA:AKE) A Risky Investment?

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.50

Dividend increased to €3.50

Consensus EPS estimates fall by 20%

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Full year 2023 earnings: EPS misses analyst expectations

Arkema S.A. to Report Q2, 2024 Results on Aug 01, 2024

Arkema S.A. (ENXTPA:AKE) acquired an unknown minority stake in Tiamat.

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

An Intrinsic Calculation For Arkema S.A. (EPA:AKE) Suggests It's 37% Undervalued

Arkema S.A. (ENXTPA:AKE) acquired Arc Bulding Products.

Arkema S.A. (ENXTPA:AKE) completed the acquisition of 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity.

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Arkema S.A. to Report Q1, 2024 Results on May 07, 2024

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Arkema S.A., Annual General Meeting, May 15, 2024

Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 44%?

Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?

Second quarter 2023 earnings: EPS in line with expectations, revenues disappoint

Now 21% undervalued

Arkema S.A. (ENXTPA:AKE) agreed to acquire a 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity for approximately €730 million.

Arkema S.A. (ENXTPA:AKE) agreed to acquire a 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity for approximately €730 million.

Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

Consensus EPS estimates increase by 11%

Arkema S.A. agreed to acquire Polytec PT GmbH Polymere Technologien.

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.40

Arkema S.A. Appoints Florence Lambert and Séverin Cabannes as Director

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 25%?

Upcoming dividend of €3.40 per share at 3.9% yield

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Why Arkema S.A. (EPA:AKE) Could Be Worth Watching

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.40

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 11%, revenue upgraded

Arkema's (EPA:AKE) Dividend Will Be Increased To €3.40

Full year 2022 earnings: EPS misses analyst expectations

Arkema S.A. Announces Executive Changes

Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 31%?

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Prayon S.A. completed the acquisition of Febex S.A from Arkema S.A. (ENXTPA:AKE).

Arkema S.A. to Report Q1, 2023 Results on May 05, 2023

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

Prayon S.A. entered into an agreement to acquire Febex S.A from Arkema S.A. (ENXTPA:AKE).

Price target decreased to €104

Price target decreased to €106

At €76.10, Is Arkema S.A. (EPA:AKE) Worth Looking At Closely?

Arkema S.A. (ENXTPA:AKE) acquired Polimeros Especiales, S.A. De C.V.

Arkema S.A. to Report Fiscal Year 2022 Results on Feb 23, 2023